| Abstract |
Objective To explore the effect of daying-35 combined with metformin in the treatment of obesity polycystic ovary syndrome. Methods A total of 60 patients with obese polycystic ovary syndrome received by our hospital from February 2021 to February 2022 were selected as the research objects. According to the principle of random allocation, they were divided into control group and study group, with 30 cases in each group. The control group was given tayin-35, and the study group was given tayin-35 combined with metformin. Obser- vation and comparison of serum sex hormone, body mass index, blood lipid, blood glucose, insulin and clinical treatment effect of two groups of patients. Results The indexes of LH, FSH, T, BMI, TC, TG, FBG and FINS in study group were significantly better than those in control group (P<0.05). The total effective rate of 28 patients (93.33%) in the study group was significantly higher than that in the control group 19 patients (63.33%), and the difference was statistically significant (P<0.05). Conclusion The clinical effect of daying -35 combined with metformin in the treatment of obese polycystic ovary syndrome is relatively obvious, which can effectively improve the serum sex hormone index, blood glucose, blood lipid and insulin levels of patients, contribute to the improvement of various indicators of patients, improve the recovery rate of patients, and has high clinical app- lication value.
|